Pragmatech, a Spanish HealthTech startup targeted on AI options in pharmacology, microbiology, and infectious illnesses, has raised €650k in funding to spice up the business deployment of iAST®, its antibiotic prescribing software program that obtained CE marking in July 2025.
The spherical was led by First Drop, which invested €300k, and included Urriellu Ventures with €175k. The spherical additionally comprised an ENISA mortgage of €180k and the conversion into fairness of €162,500 in convertible notes from a earlier spherical.
Pragmatech is an Oviedo-based startup based in 2021. In line with the corporate, its flagship product, iAST®, is the primary CE-marked AI-powered software program designed to help scientific decision-making in antibiotic prescription. It has been clinically confirmed to scale back prescribing errors and advocate therapies with decrease resistance potential, it claims.
“With this funding spherical, we’re strengthening our capability to deliver iAST® to the hospitals and healthcare professionals who want it most. The help of traders like First Drop and Urriellu Ventures reinforces confidence in our know-how and the constructive influence it’s having on scientific follow,” stated Javier Fernández, co-CEO of Pragmatech.
With a B2B mannequin, the corporate goals to steer the digital transformation of infectious illness administration, enhancing affected person outcomes and healthcare system sustainability.
Pablo Valledor, co-CEO and CTO, stated, “This funding not solely allows us to roll out iAST® at a business degree, but in addition gives us with the assets essential to proceed refining our merchandise and to make sure that synthetic intelligence helps scientific decision-making in a secure and efficient method.”
